Ever Source Wealth Advisors, LLC Glycomimetics Inc Transaction History
Ever Source Wealth Advisors, LLC
- $1.48 Billion
- Q3 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Glycomimetics Inc stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 4,755 shares of GLYC stock, worth $1,854. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,755
Previous 4,755
-0.0%
Holding current value
$1,854
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding GLYC
# of Institutions
35Shares Held
17.8MCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA9.54MShares$3.72 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$1.04 Million0.0% of portfolio
-
Siren, L.L.C. New York, NY1.97MShares$766,3940.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny781KShares$304,6290.0% of portfolio
-
Black Rock Inc. New York, NY723KShares$282,0410.0% of portfolio
About GLYCOMIMETICS INC
- Ticker GLYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,423,900
- Market Cap $20.4M
- Description
- GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...